Novel chemotherapeutic agents for the treatment of brain cancer

By Newton H.B.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2815-2829

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenic agents for the treatment of glioblastoma

By Gerstner Elizabeth R   Duda Dan G   Tomaso Emmanuelle di   Sorensen Greg   Jain Rakesh K   Batchelor Tracy T  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1895-1908

Informa Healthcare

Access to resources Recommend Favorite

Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme

By Martikainen Janne A.  

PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. : 803-815

Adis International

Access to resources Recommend Favorite

Antiangiogenesis Treatment for Glioblastoma Multiforme: Challenges and Opportunities

By Wong Eric T.   Brem Steven  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 5, 2008-05 ,pp. : 515-522

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The Emerging Role of Stereotactic Radiosurgery in the Treatment of Glioblastoma Multiforme

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 4, 2012-10 ,pp. : 292-299

Bentham Science Publishers

Access to resources Recommend Favorite